Most patients with early active relapsing-remitting MS treated with ocrelizumab did not see worse hand function or ambulation ...
Medthera's WalkPort is designed to help people with mobility and gait issues, including those with MS, safely stand and ...
Researchers have identified two compounds, K102 and K110, that could repair the nerve damage from multiple sclerosis. These drugs help regenerate the protective myelin sheath and balance immune ...
In the past, when researchers modeled quadruped gaits — how four-legged organisms walk, run and move — gaits have been modeled with separate neural networks, according to Professor and Associate Chair ...
Grace Miller was a 24-year-old law school student when she was diagnosed with multiple sclerosis. Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive content.
Living with multiple sclerosis (MS) often means managing a mix of symptoms that affect daily life, including fatigue, mobility challenges, pain, and changes in strength and endurance. Body weight can ...
Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and safety in diverse patient populations. The MUSETTE trial confirmed that the ...
Forbes contributors publish independent expert analyses and insights. Gus Alexiou is a London-based reporter covering disability inclusion. After receiving U.S. Food and Drug Administration clearance ...
Abstract: Gait analysis plays a crucial role in assessing mobility impairments and monitoring disease progression in individuals with Multiple Sclerosis (MS). Markerless, video-based methods offer a ...
In the human brain, neurofilament light chain (NfL, shown in brown) is seen in brain cells and the neural wires that connect them. UCSF researchers found NfL in the bloodstream of patients who would ...
A new study published in Scientific Reports indicates that amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS) have an extremely high geographic association, even after controlling for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results